NetScientific

Vortex Biosciences, Inc., established in 2010 and headquartered in Palo Alto, California, specializes in developing liquid biopsy technology for cancer diagnosis and monitoring. The company integrates cancer biology, microfluidic engineering, and informatics to deliver advanced tools for isolating and characterizing circulating tumor cells (CTCs). Vortex's flagship product is the VTX-1 Liquid Biopsy System, which automates the label-free isolation and collection of viable CTCs directly from whole blood, enabling healthcare institutions and professionals to make informed therapeutic decisions efficiently.

Founded in 2011, Sofant Technologies specializes in designing and licensing smart antenna and tunable RF solutions for smartphone and tablet manufacturers. Its offerings include compact smart antenna solutions, tunable impedance matching modules, RF MEMS capacitors, and phase shifters, aiming to enhance performance while reducing power consumption and heat.

Vortex Biosciences, Inc., established in 2010 and headquartered in Palo Alto, California, specializes in developing liquid biopsy technology for cancer diagnosis and monitoring. The company integrates cancer biology, microfluidic engineering, and informatics to deliver advanced tools for isolating and characterizing circulating tumor cells (CTCs). Vortex's flagship product is the VTX-1 Liquid Biopsy System, which automates the label-free isolation and collection of viable CTCs directly from whole blood, enabling healthcare institutions and professionals to make informed therapeutic decisions efficiently.

Q-Bot Limited, established in 2012 and headquartered in London, UK, specializes in the manufacture of robotic tools designed to move beneath floors, applying insulation to floorboards. This innovative solution aims to improve building energy efficiency while minimizing disruption during installation. The company's robotics platform has broader applications across various industries, supported by a combination of government grants, private investments, and sales revenue. Notable backers include Climate-KIC, The Technology Strategy Board, and The Department for Energy and Climate Change.

Vortex Biosciences, Inc., established in 2010 and headquartered in Palo Alto, California, specializes in developing liquid biopsy technology for cancer diagnosis and monitoring. The company integrates cancer biology, microfluidic engineering, and informatics to deliver advanced tools for isolating and characterizing circulating tumor cells (CTCs). Vortex's flagship product is the VTX-1 Liquid Biopsy System, which automates the label-free isolation and collection of viable CTCs directly from whole blood, enabling healthcare institutions and professionals to make informed therapeutic decisions efficiently.

Q-Bot Limited, established in 2012 and headquartered in London, UK, specializes in the manufacture of robotic tools designed to move beneath floors, applying insulation to floorboards. This innovative solution aims to improve building energy efficiency while minimizing disruption during installation. The company's robotics platform has broader applications across various industries, supported by a combination of government grants, private investments, and sales revenue. Notable backers include Climate-KIC, The Technology Strategy Board, and The Department for Energy and Climate Change.

EpiBone is a biotechnology company specializing in regenerative medicine for bone repair. It uses patient-specific stem cells and 3D fabrication to create living, anatomically precise bone grafts. The company's lead product has completed Phase I/IIa clinical trials, with additional products focusing on cartilage repair under development.

Founded in 2011, Sofant Technologies specializes in designing and licensing smart antenna and tunable RF solutions for smartphone and tablet manufacturers. Its offerings include compact smart antenna solutions, tunable impedance matching modules, RF MEMS capacitors, and phase shifters, aiming to enhance performance while reducing power consumption and heat.

PointGrab Ltd. is a technology company based in Hod Hasharon, Israel, specializing in machine learning solutions for optical Internet of Things (IoT) devices aimed at home and building automation. Founded in 2008, PointGrab develops advanced optical sensors that integrate with connected lighting fixtures and other building systems to enhance the management of commercial real estate. Its flagship product, PointSwitch, utilizes machine learning algorithms to provide various functionalities, including occupancy sensing, ambient light sensing, and behavior analytics of occupants. This technology allows organizations to optimize their real estate efficiency while ensuring employee privacy and welfare, positioning PointGrab as a leader in smart building solutions.

Founded in 2015, SageTech Medical develops innovative anesthetic technology for human and veterinary healthcare providers. Its patented process captures, extracts, and purifies inhalational anaesthetic agents, reducing costs and environmental pollution. The company offers solutions ranging from industrial-scale bulk capture to integrated recycling systems within anaesthetic machines.

ProAxsis Ltd. is a biotechnology company that focuses on developing laboratory-based immunoassays and rapid point-of-care tests for the capture, detection, and measurement of active protease biomarkers associated with various diseases. The company's innovative tests utilize patented ProteaseTags®, which are designed to trap active proteases within complex biological samples, allowing for a visual readout of their presence. ProAxsis has validated several active protease species as biomarkers of disease activity in conditions such as cancer, infections, and respiratory diseases, including bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). In 2016, the company registered its first immunoassay for the specific measurement of active neutrophil elastase, a significant biomarker for lung infection and inflammation, with a European CE Mark, highlighting its commitment to advancing medical diagnostics.

EMV Capital is a venture capital firm specializing in early-stage investments in high-growth deep tech companies focused on life science, sustainability, and industrial sectors across the UK and internationally.

ProAxsis Ltd. is a biotechnology company that focuses on developing laboratory-based immunoassays and rapid point-of-care tests for the capture, detection, and measurement of active protease biomarkers associated with various diseases. The company's innovative tests utilize patented ProteaseTags®, which are designed to trap active proteases within complex biological samples, allowing for a visual readout of their presence. ProAxsis has validated several active protease species as biomarkers of disease activity in conditions such as cancer, infections, and respiratory diseases, including bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). In 2016, the company registered its first immunoassay for the specific measurement of active neutrophil elastase, a significant biomarker for lung infection and inflammation, with a European CE Mark, highlighting its commitment to advancing medical diagnostics.

Nuada is a vertically integrated company specializing in carbon capture technology aimed at decarbonizing heavy industries. The firm develops next-generation point-source capture solutions designed to facilitate energy-efficient CO2 filtration for industrial emitters in sectors that are difficult to decarbonize. By offering innovative technologies, Nuada enables these industries to meet their Net Zero targets while minimizing financial impacts. The company is committed to providing effective environmental solutions that address the challenges of carbon emissions in various industrial applications.